GB2407496A — Method for forming a polysiloxane film on a biological surface
Assigned to Dow Silicones Corp · Expires 2005-05-04 · 21y expired
What this patent protects
This invention relates to a method for forming a film on a biological surface. The method comprises mixing 5 to 70 wt. % of an alkylene trialkoxysilyl terminated polysiloxane; 0 to 5 wt. % of an alkoxysilane; 0.01 to 5 wt. % of a catalyst; 0 to 25 wt % of a filler; and 1 to 94.99…
USPTO Abstract
This invention relates to a method for forming a film on a biological surface. The method comprises mixing 5 to 70 wt. % of an alkylene trialkoxysilyl terminated polysiloxane; 0 to 5 wt. % of an alkoxysilane; 0.01 to 5 wt. % of a catalyst; 0 to 25 wt % of a filler; and 1 to 94.99 wt % of a volatile diluent to form a formulation. The formulation is then applied onto a biological surface where it cures in situ on the biological surface to form the film. The resultant film is useful in healthcare and cosmetic applications, as well as pesticidal or herbicidal applications. The preferred formulations include a polysiloxane produced from vinyl-terminated dimethylsiloxane and trimethoxysilylethyl tetramethyldisiloxane, methyltrimethoxysilane as the alkoxysilane, tetra-tert-butyl titanate as the catalyst and hexamethyldisiloxane as the diluent. The formulation may contain an active agent and may be applied to skin, hair, nails, teeth eyes, mucous membranes or to plants.
Drugs covered by this patent
- Jublia (EFINACONAZOLE) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.